Quince Therapeutics
QNCX
#8426
Rank
NZ$0.37 B
Marketcap
NZ$6.68
Share price
-1.03%
Change (1 day)
91.71%
Change (1 year)

Quince Therapeutics (QNCX) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : NZ$0.18 Billion

According to Quince Therapeutics's latest financial reports the company's total liabilities are NZ$0.18 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Quince Therapeutics - Total liabilities on balance sheet (from 2018 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.14 B14.19%
2023-12-31NZ$0.13 B2406.58%
2022-12-31NZ$5.22 M-75.63%
2021-12-31NZ$21.43 M-10.09%
2020-12-31NZ$23.84 M80.59%
2019-12-31NZ$13.2 M-91.61%
2018-12-31NZ$0.15 B298.97%
2017-12-31NZ$39.42 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$41.97 M-76.99%๐Ÿ‡บ๐Ÿ‡ธ USA